-
Kubayi Warns Residents to Vacate Hijacked Buildings as State Prepares Seizures
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Binance Secures $6.5 Billion Asset-Freezing Order from Abu Dhabi Court
-
محكمة الاحتلال تمدد اعتقال مدير مستشفى كمال عدوان دون تهمة
-
Malta PM Abela Refuses Parliamentary Question on Maritime Borders Amid Turkey-Libya Deal
-
Global Scams Remain Widespread: Nearly Two in Three Adults Worldwide Report Scam Encounters, 9% Lost Money
-
محافظ طولكرم يدعو لمبادرة مجتمعية لخفض تكاليف الأعراس وتعزيز التكافل
-
OPEC Chief: Oil to Remain Major Energy Source for Decades Amid Global Shift
-
Shinde Clarifies Torn Photo Controversy Amid Sonia Gandhi Book Protest
-
Hyundai Offers £1,000 Deposit Contribution on Black Friday for Tucson, Santa Fe, Kona, Ioniq 9 and Bayon
Morocco starts construction of anti-Covid vaccine plant
Morocco on Thursday inaugurated construction of an anti-Covid vaccine manufacturing plant in partnership with Swedish firm Recipharm, the official news agency MAP reported.
The factory to be known as Sensyo Pharmatech will produce vaccines against coronavirus and other diseases, with production expected to reach 116 million units in 2024, MAP said.
It was launched in Benslimane, a region of Morocco's economic hub Casablanca during a ceremony attended by King Mohammed VI, it said.
The plant will need investments of between 400-500 million euros ($445 million-$557 million).
It is aimed at ensuring vaccine "self-sufficiency" for the North African kingdom, MAP said.
Its goal is to make, between 2022 and 2025, "active substances for more than 20 vaccines, three of which would be against coronavirus... to cover 70 percent of the kingdom's needs and more than 60 percent of needs across Africa", the agency said.
Morocco is already producing the Chinese anti-Covid Sinopharm vaccine, with more than three million doses being made per month.
By next month it plans on producing five million doses and more than 20 million by the end of the year.
Home to 36 million inhabitants, Morocco is hoping that its vaccination drive will help eradicate Covid-19. More than 23 million people have already received a second dose against coronavirus, according to the health ministry.
Authorities hope to vaccinate 80 percent of the population with either Sinopharm or Pfizer-BioNTech.
In July, Recipharm said it had signed a memorandum of understanding with Morocco and a consortium of the country's leading banks to build a factory to produce vaccines and biotherapeutics in the kingdom.
As part of the deal, it said in a statement at the time, $500 million would be invested into the project by the Moroccan government and consortium.
"The investment is primarily to supply the African continent and help it gain vaccine sovereignty and access to future biotherapeutics," it said.
M.Qasim--SF-PST